The effects of tacrolimus on cognitive functions in a rat model of cerebral vasospasm
| dc.contributor.author | Sahinturk, F. | |
| dc.contributor.author | Sonmez, E. | |
| dc.contributor.author | Altinors, N. | |
| dc.contributor.orcID | 0000-0002-0471-3177 | en_US |
| dc.contributor.researcherID | AAI-7972-2021 | en_US |
| dc.date.accessioned | 2022-08-16T08:45:59Z | |
| dc.date.available | 2022-08-16T08:45:59Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Aim: The present study aims to demonstrate the efficacy of tacrolimus (TAC), an agent showing immunosuppressive effects through calcineurin inhibition, in the treatment of subarachnoid haemorrhage (SAH)-induced cerebral vasospasm in rat models. Material and Methods: The study, after gaining the approval of the ethics committee, included 18 male Sprague-Dawley rats which were allowed to swim in four directions within a Morris water maze until the cognitive function curves reached a plateau (4 days). After the retention swimming, four extremities were found while the rats were held in a prone position with the head at 20 degrees flexion under general anaesthesia. SAH was induced through the administration of 0.4 cc/ kg of autologous arterial blood into the cisterna magna. Tacrolimus (0.5 mg/ kg, 2 doses) was administered intraperitoneally for the treatment of the induced vasospasm, and its effi cacy was investigated. Conclusion: When the threeday all-direction swimming times of the control, of SAH and SAH-TAC groups were compared, a decrease was noted in the mean times of swimming within the group administered with tacrolimus after SAH, although a Kruskal-Wallis variance analysis did not indicate any significant difference in the distribution of the mean three-day swimming times between control, SAH and SAH-TAC groups, at a 95% confidence interval (P = 0.366). | en_US |
| dc.identifier.endpage | 198 | en_US |
| dc.identifier.issn | 1210-7859 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.scopus | 2-s2.0-85107617511 | en_US |
| dc.identifier.startpage | 195 | en_US |
| dc.identifier.uri | http://hdl.handle.net/11727/7352 | |
| dc.identifier.volume | 84 | en_US |
| dc.identifier.wos | 000694710200012 | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.isversionof | 10.48095/cccsnn2021195 | en_US |
| dc.relation.journal | CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | tacrolimus | en_US |
| dc.subject | vasospasm | en_US |
| dc.subject | cognitive function | en_US |
| dc.title | The effects of tacrolimus on cognitive functions in a rat model of cerebral vasospasm | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: